Scott Alexander updates on Lumina probiotic, discussing FDA trials, effectiveness, potential risks, and his nuanced stance on the product. Longer summary

Scott Alexander provides updates on Lumina, a genetically modified anti-tooth-decay bacterium. He clarifies information about FDA testing, discusses rat trial results, reports on recent colonization studies, addresses potential side effects, and shares some anecdotal results. Scott also explains his stance on Lumina, emphasizing that while he sees potential benefits, he doesn't fully endorse it and acknowledges the uncertainties and risks involved. Shorter summary

Scott Alexander reviews Lantern Bioworks' Lumina, a genetically modified bacterium designed to prevent tooth decay, discussing its science, safety, and commercialization plans. Longer summary

Scott Alexander discusses Lantern Bioworks' new product, Lumina, a genetically modified bacterium designed to prevent tooth decay. The post covers the science behind the product, its origins, usage, potential risks, and the company's plans for commercialization. Scott explains the genetic modifications made to the bacterium, addresses safety concerns, and discusses the regulatory path Lantern is pursuing. The article also touches on the product's pricing strategy and availability. Shorter summary